Labeling, Advertising & Promotion

Torrey Pines Law Group's attorneys and regulatory advisors have substantial experience providing strategic advice with respect to drug and medical device labeling, advertising and promotion.

Our team has helped clients in this increasingly complex legal and regulatory landscape in which advertising claims are scrutinized by foreign, federal, and state governments. In the US, our attorneys and advisors have experience with litigation, developing legal opinions, and advising clients related to Lanham Act false advertising, unfair competition, FDA labeling rules, Stark Laws, Anti-Kickback, trademark, copyright, rights of publicity, and federal privacy and data security (e.g., HIPAA and GDPR).